What they were paid
RECURSION PHARMACEUTICALS Director Compensation Table · all 3 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $58,983 | $112,502 | $136,675 | $0 | $308,160 |
| FY2024 | $54,997 | $112,503 | $136,727 | — | $304,278 |
| FY2022 | $55,000 | $112,499 | $130,644 | — | $298,143 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: RECURSION PHARMACEUTICALS, INC. DEF 14A filed April 30, 2026, accession 0001601830-26-000065, and prior-year filings. Open the filing on EDGAR.
How this page was built: the RECURSION PHARMACEUTICALS, INC. filed document, accession 0001601830-26-000065. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2026.
Get the RECURSION PHARMACEUTICALS Board Governance Report
$308,160 Zavain Dar, FY2025 total director compensation
$500
The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.
Data as of April 30, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
How this board is paid
company policy · FY2025RECURSION PHARMACEUTICALS pays directors a $35,000 cash retainer and $112,500 in equity.
Committees
FY2025 · as the proxy prints themAudit · Nominating/Governance (Chair) · Technology · Strategic Transactions and Finance · Corporate Social Responsibility
The rest of the RECURSION PHARMACEUTICALS board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Blake Borgeson | Independent Director | $307,149 |
| Christopher Gibson | Chair of the Board | — |
| Dean Y. Li | Independent Director | $290,732 |
| Elaine Sun | Independent Director | $741,570 |
| Franziska Michor | Independent Director | $296,136 |
| Najat Khan | Director | — |
| Namandj Bumpus | Independent Director | $731,605 |
| Robert Hershberg | Lead Independent Director | $333,163 |
| Zachary Bogue | Independent Director | $0 |
The full RECURSION PHARMACEUTICALS compensation record
free company briefThis page is one director within RECURSION PHARMACEUTICALS's record. The company brief lists every named executive and director, each linking to their own page.
Peer companies
named in the RECURSION PHARMACEUTICALS proxy · each links to its own free briefOrder RXRX
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.